Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/213107
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Resistant/Refractory Hypertension and Sleep Apnoea: Current Knowledge and Future Challenges |
Autor: | Oscullo, Grace; Torres, Gerard; Campos-Rodríguez, Francisco CSIC ORCID; Posadas, Tomás; Reina-González, Ángela; Sapiña-Beltrán, Esther; Barbé, Ferrán; Martínez-García, Miguel Ángel | Palabras clave: | Resistant hypertension Refractory hypertension Obstructive sleep apnoea Continuous positive airway pressure |
Fecha de publicación: | 5-nov-2019 | Editor: | Multidisciplinary Digital Publishing Institute | Citación: | Journal of Clinical Medicine 8(11): 1872 (2019) | Resumen: | Hypertension is one of the most frequent cardiovascular risk factors. The population of hypertensive patients includes some phenotypes whose blood pressure levels are particularly difficult to control, thus putting them at greater cardiovascular risk. This is especially true of so-called resistant hypertension (RH) and refractory hypertension (RfH). Recent findings suggest that the former may be due to an alteration in the renin–angiotensin–aldosterone axis, while the latter seems to be more closely related to sympathetic hyper-activation. Both these pathophysiological mechanisms are also activated in patients with obstructive sleep apnoea (OSA). It is not surprising, therefore, that the prevalence of OSA in RH and RfH patients is very high (as reflected in several studies) and that treatment with continuous positive airway pressure (CPAP) manages to reduce blood pressure levels in a clinically significant way in both these groups of hypertensive patients. It is therefore necessary to incorporate into the multidimensional treatment of patients with RH and RfH (changes in lifestyle, control of obesity and drug treatment) a study of the possible existence of OSA, as this is a potentially treatable disease. There are many questions that remain to be answered, especially regarding the ideal combination of treatment in patients with RH/RfH and OSA (drugs, renal denervation, CPAP treatment) and patients’ varying response to CPAP treatment. | Versión del editor: | https://doi.org/10.3390/jcm8111872 | URI: | http://hdl.handle.net/10261/213107 | DOI: | 10.3390/jcm8111872 | E-ISSN: | 2077-0383 |
Aparece en las colecciones: | (IBIS) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
jcm-08-01872.pdf | 935,46 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
9
checked on 01-abr-2024
SCOPUSTM
Citations
19
checked on 21-abr-2024
WEB OF SCIENCETM
Citations
15
checked on 24-feb-2024
Page view(s)
143
checked on 27-abr-2024
Download(s)
112
checked on 27-abr-2024